Loading...
11 Germany Central Nervous System Drugs Reports
Country Covered: Germany
Study Period: 2019 - 2030
Major Players: Abbott Laboratories, Axogen, Medtronic, Boston Scientific, Integra LifeSciences
Country Covered: Germany
Study Period: 2019 - 2030
Major Players: Abbvie, Eli Lilly and Company, Advin Health Care, Dermavant, Brickell Biotech
Country Covered: Germany
Study Period: 2019 - 2030
Major Players: Bioness, Saebo, Boston Orthotics & Prosthetics, Ottobock, Ossur
Country Covered: Germany
Study Period: 2019 - 2030
Major Players: Pfizer, Eli Lilly and Company, GlaxoSmithKline, Novartis, Viatris
Country Covered: Germany
Study Period: 2019 - 2030
Major Players: Zimmer Biomet, Anika Therapeutics, Bioventus, Ferring Pharmaceuticals, Sanofi
Country Covered: Germany
Study Period: 2019 - 2030
Major Players: Biogen, Novartis, Merck, Eli Lilly and Company, Johnson & Johnson
Country Covered: Germany
Study Period: 2019 - 2030
Major Players: Medtronic, AngioDynamics, Lumenis, Teleflex, Quanta System
Country Covered: Germany
Study Period: 2019 - 2030
Major Players: Ironshore Pharmaceuticals, Novartis, Takeda Pharmaceuticals, Azurity Pharmaceuticals, Noven Therapeutics
Country Covered: Germany
Study Period: 2019 - 2030
Major Players: Janssen, Abbvie, UCB, Amgen, Novartis
Country Covered: Germany
Study Period: 2019 - 2030
Major Players: Novartis, Abbvie, Amgen, Boehringer Ingelheim, UCB
Country Covered: Germany
Study Period: 2019 - 2030
Major Players: Sorrento Therapeutics, Eliem Therapeutics, Scilex Holding, Sinfonia Biotherapeutics, Vita Science